Adenocarcinoma of unknown primary site

Song, Seo Young; Kim, Won Seog; Lee, Hye Ran; Jeong, Hyun Sik; Lee, Nam Su; Oh, Sung Yong; Kim, Ji Hyang; Kim, Kihyun; Nam, Eun Mi; Oh, Young Ryun; Jung, Chul Won; Yoon, Sung Soo; Im, Young Hyuck; Lee, Hong Gui; Kang, Won Ki; Park, Chan Hyung; Park, Keunchil

Abstract

BACKGROUND
To study clinical characteristics and treatment outcomes of adenocarcinoma of unknown primary site (ACUPS).
METHODS
A retrospective analysis of 81 patients who were diagnosed as ACUPS, seen at Samsung Medical Center from May, 1995 to July, 1999, was performed.
RESULTS
The median age of the patients was 58 years. The common sites of metastases were the lymph node, liver, lung, bone. In 49 of 81 patients (60.5%), the dominant tumor location was below the diaphragm. The majority of patiens (76 of 81) were initially treated with systemic chemotherapy including cisplatin. Responses were evaluable in 70 of 76. Eighteen of 70 patients (25.7%) responded to chemotherapy and complete remission was observed in 6 patients. The overall median survival of 81 patients was 5.6 months. The median survival of the responding patients was 18.3 months but the median survial of the nonresponding patients was 4.6 months (p<0.01). In univariate and multivariate analysis, age, performance status and response to initial chemotherapy were significant prognostic factors for overall survial.
CONCLUSION
Poor survival rate and treatment response were observed in ACUPS but complete response and long-term survival were observed in several patients.